CBP Emeritus Faculty Member, Dr. Michael O'Rand's Biotech Company Receives Funding for Developing Male Contraceptive Pill - Department of Cell Biology and Physiology

UNC Chapel Hill
UNC Health
Intranet
Login

January 20, 2023

Eppin Pharma has partnered with the nonprofit Male Contraceptive Initiative (MCI), which has provided the company a program related investment of up to $800,000. Read full article featured on WRAL TechWire.

Make a Gift

CBP Emeritus Faculty Member, Dr. Michael O’Rand’s Biotech Company Receives Funding for Developing Male Contraceptive Pill

Make a Gift

More from Department of Cell Biology and Physiology